Daré Bioscience, Inc. (DARE)
0.8428
-0.01
(-0.96%)
USD |
NASDAQ |
Oct 02, 16:00
0.8353
-0.01
(-0.89%)
After-Hours: 20:00
Daré Bioscience Market Cap : 12.78M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 12.78M |
| October 01, 2026 | 12.91M |
| September 30, 2026 | 12.94M |
| September 29, 2026 | 12.36M |
| September 28, 2026 | 11.38M |
| September 25, 2026 | 11.76M |
| September 24, 2026 | 11.23M |
| September 23, 2026 | 12.25M |
| September 22, 2026 | 12.89M |
| September 21, 2026 | 12.29M |
| September 18, 2026 | 11.90M |
| September 17, 2026 | 11.34M |
| September 16, 2026 | 11.01M |
| September 15, 2026 | 11.08M |
| September 14, 2026 | 11.17M |
| September 11, 2026 | 10.71M |
| September 10, 2026 | 10.70M |
| September 09, 2026 | 10.87M |
| September 08, 2026 | 10.82M |
| September 04, 2026 | 10.94M |
| September 03, 2026 | 10.82M |
| September 02, 2026 | 11.23M |
| September 01, 2026 | 11.68M |
| August 31, 2026 | 11.54M |
| August 28, 2026 | 11.15M |
| Date | Value |
|---|---|
| August 27, 2026 | 11.21M |
| August 26, 2026 | 11.39M |
| August 25, 2026 | 12.45M |
| August 24, 2026 | 12.16M |
| August 21, 2026 | 12.44M |
| August 20, 2026 | 12.28M |
| August 19, 2026 | 12.51M |
| August 18, 2026 | 11.65M |
| August 17, 2026 | 12.29M |
| August 14, 2026 | 14.11M |
| August 13, 2026 | 20.78M |
| August 12, 2026 | 21.84M |
| August 11, 2026 | 21.84M |
| August 10, 2026 | 19.80M |
| August 07, 2026 | 20.38M |
| August 06, 2026 | 19.36M |
| August 05, 2026 | 19.51M |
| August 04, 2026 | 19.51M |
| August 03, 2026 | 18.64M |
| July 31, 2026 | 17.76M |
| July 30, 2026 | 18.05M |
| July 29, 2026 | 16.89M |
| July 28, 2026 | 17.25M |
| July 27, 2026 | 19.22M |
| July 24, 2026 | 18.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Elite Pharmaceuticals, Inc. | 246.29M |
| Eton Pharmaceuticals, Inc. | 1.566B |
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.54B |
| Veru, Inc. | 42.80M |
Market Cap Related Metrics
| PS Ratio | 8.741 |
| Price | 0.8428 |
| Earnings Yield | -93.21% |